These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9797251)

  • 21. In vitro activity of coumermycin A1 against Mycobacterium tuberculosis var. hominis.
    Duma RJ; Warner JF
    Appl Microbiol; 1969 Sep; 18(3):404-5. PubMed ID: 4984765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative class.
    Biava M; Porretta GC; Poce G; Deidda D; Pompei R; Tafi A; Manetti F
    Bioorg Med Chem; 2005 Feb; 13(4):1221-30. PubMed ID: 15670931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reporter gene technology to assess activity of antimycobacterial agents in macrophages.
    Arain TM; Resconi AE; Singh DC; Stover CK
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1542-4. PubMed ID: 8726035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activities against mycobacteria of two long-acting rifamycins, FCE22807 and CGP40/469A (SPA-S-565).
    Dickinson JM; Mitchison DA
    Tubercle; 1990 Jun; 71(2):109-15. PubMed ID: 2120827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection.
    Poce G; Bates RH; Alfonso S; Cocozza M; Porretta GC; Ballell L; Rullas J; Ortega F; De Logu A; Agus E; La Rosa V; Pasca MR; De Rossi E; Wae B; Franzblau SG; Manetti F; Botta M; Biava M
    PLoS One; 2013; 8(2):e56980. PubMed ID: 23437287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis.
    Liu P; Yang Y; Ju Y; Tang Y; Sang Z; Chen L; Yang T; An Q; Zhang T; Luo Y
    Bioorg Chem; 2018 Oct; 80():422-432. PubMed ID: 30005200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains.
    Carta A; Palomba M; Paglietti G; Molicotti P; Paglietti B; Cannas S; Zanetti S
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4791-4. PubMed ID: 17604166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Mycobacterial Activity of Tamoxifen Against Drug-Resistant and Intra-Macrophage Mycobacterium tuberculosis.
    Jang WS; Kim S; Podder B; Jyoti MA; Nam KW; Lee BE; Song HY
    J Microbiol Biotechnol; 2015 Jun; 25(6):946-50. PubMed ID: 25639719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
    Khan A; Sarkar S; Sarkar D
    Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and anti-mycobacterial activity of 1,2,3,5-tetrasubstituted pyrrolyl-N-acetic acid derivatives.
    Pagadala LR; Mukkara LD; Singireddi S; Singh A; Thummaluru VR; Jagarlamudi PS; Guttala RS; Perumal Y; Dharmarajan S; Upadhyayula SM; Ummanni R; Basireddy VS; Ravirala N
    Eur J Med Chem; 2014 Sep; 84():118-26. PubMed ID: 25016370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
    Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages.
    Mor N; Vanderkolk J; Heifets L
    Antimicrob Agents Chemother; 1994 May; 38(5):1161-4. PubMed ID: 8067756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
    Sato K; Tomioka H; Akaki T; Kawahara S
    Int J Antimicrob Agents; 2000 Sep; 16(1):25-9. PubMed ID: 11185410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial activity of long-chain fatty alcohols against mycobacteria.
    Mukherjee K; Tribedi P; Mukhopadhyay B; Sil AK
    FEMS Microbiol Lett; 2013 Jan; 338(2):177-83. PubMed ID: 23136919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriostatic and bactericidal activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophages.
    Mor N; Simon B; Heifets L
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1482-5. PubMed ID: 8726023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Mycobacterium tuberculosis outer membrane channel protein CpnT confers susceptibility to toxic molecules.
    Danilchanka O; Pires D; Anes E; Niederweis M
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2328-36. PubMed ID: 25645841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
    Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
    PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB).
    Martins M; Viveiros M; Ramos J; Couto I; Molnar J; Boeree M; Amaral L
    Int J Antimicrob Agents; 2009 May; 33(5):479-82. PubMed ID: 19155160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis.
    Bettencourt MV; Bosne-David S; Amaral L
    Int J Antimicrob Agents; 2000 Sep; 16(1):69-71. PubMed ID: 11185417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bactericidal activity of organic extracts from Flourensia cernua DC against strains of Mycobacterium tuberculosis.
    Molina-Salinas GM; Ramos-Guerra MC; Vargas-Villarreal J; Mata-Cárdenas BD; Becerril-Montes P; Said-Fernández S
    Arch Med Res; 2006 Jan; 37(1):45-9. PubMed ID: 16314185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.